Jagsonpal Pharmaceuticals Ltd.
NSE: JAGSNPHARM | BSE: 507789
₹236.04
₹5.54
(2.40%)
As on 30-Jul-2026IST
Market cap
₹1,561 Cr
Revenue (TTM)
₹294 Cr
P/E Ratio
34.3
P/B Ratio
6.2
Div. Yield
1.7 %
Quality Score
10/10
Growth Score
6/10
Valuation Score
5/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹45 Cr
-
ROE
28.5 %
-
ROCE
33.1 %
-
Industry P/E
37.36
-
EV/EBITDA
19.9
-
Debt to Equity
0
-
Book Value
₹38
-
EPS
₹7.1
-
Face value
2
-
Shares outstanding
65,929,470
10 Years Aggregate
CFO
₹219.26 Cr
EBITDA
₹176.72 Cr
Net Profit
₹159.11 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Jagsonpal Pharma
| 22.5 | 2.5 | 13.0 | -18.4 | 9.3 | 27.6 | 31.5 |
|
BSE Healthcare
| 16.7 | 3.4 | 13.6 | 10.6 | 22.3 | 14.7 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Jagsonpal Pharma
| -25.9 | 55.1 | 4.3 | 108.4 | 122.1 | 178.9 | -18.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Jagsonpal Pharma
|
236.0 | 1,561.2 | 293.9 | 45.5 | 17.7 | 17.8 | 34.3 | 6.2 |
| 1,466.4 | 1,18,430.1 | 28,324.4 | 3,364.8 | 14.2 | 10.6 | 35.1 | 3.4 | |
| 1,375.2 | 19,063.5 | 3,229.7 | 666.9 | 26.6 | 18.8 | 29.6 | 4.7 | |
| 2,575.9 | 1,06,427.0 | 14,737.9 | 2,055.1 | 19.9 | 13.6 | 52.1 | 6.5 | |
| 796.0 | 95.5 | 73.8 | 4.2 | 6.2 | 7.8 | 22.9 | 1.6 | |
| 4,801.3 | 21,954.6 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.9 | 5.0 | |
| 844.4 | 1,878.8 | 272.0 | 36.1 | 19.4 | 11.5 | 52 | 5.6 | |
| 4,872.1 | 1,85,263.9 | 15,723.0 | 2,156.0 | 23.4 | 26.9 | 84.9 | 22.0 | |
| 1,539.3 | 2,066.8 | 811.3 | 116.2 | 17.2 | 18.5 | 17.8 | 3.0 | |
| 44.5 | 271.3 | 44.6 | -2.5 | 0.8 | -2.6 | -- | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Jagsonpal Pharma
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of... gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India. Read more
-
Incorporated
1978
-
Chairman
Harsha Raghavan
-
Managing Director
Manish Gupta
-
Group
Jagsonpal
-
Headquarters
New Delhi, Delhi
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action- Record Date: September 04 2026
29-Jul-2026No News & Announcements are available.
FAQs for Jagsonpal Pharma
What is the current share price of Jagsonpal Pharmaceuticals Ltd Today?
The share price of Jagsonpal Pharmaceuticals Ltd is ₹236.04 (NSE) and ₹236.80 (BSE) as of 30-Jul-2026 IST. Jagsonpal Pharmaceuticals Ltd has given a return of 9.28% in the last 3 years.
What is the current PB & PE ratio of Jagsonpal Pharmaceuticals Ltd?
The P/E ratio of Jagsonpal Pharmaceuticals Ltd is 34.33 times as on 30-Jul-2026, a 8 discount to its peers’ median range of 37.36 times.
The P/B ratio of Jagsonpal Pharmaceuticals Ltd is 6.23 times as on 30-Jul-2026, a 24 premium to its peers’ median range of 5.03 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.90
|
6.58
|
|
2024
|
13.17
|
4.34
|
|
2023
|
11.37
|
5.06
|
|
2022
|
17.43
|
6.19
|
|
2021
|
4.89
|
1.83
|
What is the 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd?
The 52-week high and low of Jagsonpal Pharmaceuticals Ltd are Rs 293.37 and Rs 155.00 as of 31-Jul-2026.
What is the market cap of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd has a market capitalisation of ₹ 1,561 Cr as on 30-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Jagsonpal Pharmaceuticals Ltd?
Before investing in Jagsonpal Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.